Gisev Family Office

Gisev Family Office operates as an independent multi-family office, established to provide integrated wealth planning and strategic consulting services. The firm focuses on ensuring the continuity of both material and immaterial assets across multiple generations for its client families. They engage in private equity investments, aiming to deliver evergreen growth capital for their portfolios.

The firm was initially established in 2014 by Mario Germano, Giammaria Giuliani, and Achille Severginini. It began as a private wealth management vehicle for their respective families, both of which possess deep-rooted histories in the financial and biotechnology sectors. Following its inception, the Giuliani and Severginini families opted to extend their comprehensive wealth management services to other families, growing its client base.

Gisev Family Office has made several notable investments across diverse sectors. Their portfolio includes companies such as Syocin, Shampora, and Seed, with investments spanning Crop Tech, Genomics, and Nutraceuticals Tech. The firm's most recent investment was a Seed round in Syocin in March 2022. Additionally, Gisev Family Office participated in a Series B funding round in June 2020 for CUTISS, a biotechnology company specializing in personalized skin graft technologies for patients with extensive skin defects.

The firm's team comprises approximately 40 internal professionals dedicated to managing and advising client families. While specific individual team expertise beyond the founders' backgrounds in finance and biotechnology is not extensively detailed, their multi-generational approach underscores a commitment to long-term wealth preservation and growth through a blend of entrepreneurial spirit and traditional advisory services.